The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees

BACKGROUND: Aromatase inhibitors (AIs) substantially reduce breast cancer mortality in clinical trials, but high rates of nonadherence to these long-term oral therapies have reduced their impact outside of trials. We examined the association of generic AI availability with AI adherence among a large...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: Neuner, Joan M., Kamaraju, Sailaja, Charlson, John A., Wozniak, Erica M., Smith, Elizabeth C., Biggers, Alana, Smallwood, Alicia J., Laud, Purushottam W., Pezzin, Liliana E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580559/
https://ncbi.nlm.nih.gov/pubmed/25971298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv130
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky